Sign inJoin waitlistJoin the waitlist

Wayne Marasco

Principal Investigator, Marasco Lab - Dana Farber Cancer Institute · Beth Israel Deaconess Medical Center

Credentials: · · ·

History

Beth Israel Deaconess Medical Center
Present

"Pioneer of Medical Progress"
2007–2009
University of Connecticut School of Medicine
University of Connecticut School

Research

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Nature Structural & Molecular Biology · 2009 · Last of 19 authors · 993 citations
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Nature Biotechnology · 2005 · 822 citations
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
The EMBO Journal · 2005 · 755 citations

Peter Ward
10 papers
DF
Douglas Feltner
6 papers
Jihua Cheng
5 papers · 2 as a resident
JF
Joseph Fantone
5 papers
RF
Robert Finberg
5 papers
Sabina Signoretti
5 papers · 2 as a fellow
CP
Christy Pacheco
4 papers
Erol Fikrig
4 papers
Toni Choueiri
3 papers
Aram Demirjian
2 papers · 2 as a resident
CN
Cody Nelson
2 papers · 1 as a fellow
David Barbie
2 papers

Grants

Heritable Immunization of the White-Footed Mouse Reservoir of Lyme Disease
National Institute of Allergy and Infectious Diseases · R01
PI · $4.7M · Massachusetts Institute of Technology
2021–2027
In vivo Testing of an Agonistic Anti-GITR mAb That Induces Cell Surface Clustering to Augment Signal Transduction and a 2nd Gen Bispecific Anti-GITR/PD1 Ab Derivative for Improved Anti-Tumor Activity
National Cancer Institute · R21
Contact PI · $476.3K · Dana-Farber Cancer Inst
2024–2027
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $5.9M · Dana-Farber Cancer Inst
2021–2026
Serologic and Molecular Studies of Human Anti-hCoV Antibody Cross-Immunity and Protective Responses Among Endemic HCoVs and SARS-CoV2
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.7M · Dana-Farber Cancer Inst
2021–2026